中银港股通医药混合发起A(020397)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
2,795,135.94 |
36,106,954.70 |
24,004,538.07 |
454,271.92 |
| 存出保证金 |
114,355.77 |
47,884.03 |
2,124,993.44 |
9,138.25 |
| 交易性金融资产 |
1,380,916,137.42 |
2,008,576,445.65 |
724,087,635.77 |
103,759,078.38 |
| 其中：股票投资 |
1,302,953,879.78 |
1,894,733,325.57 |
686,450,736.59 |
98,112,689.78 |
| 债券投资 |
77,962,257.64 |
113,843,120.08 |
37,636,899.18 |
5,646,388.60 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
10,745,240.72 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
250,229.55 |
- |
373,762.30 |
- |
| 应收申购款 |
25,409,053.65 |
30,842,257.26 |
37,442,062.43 |
798,177.82 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,476,816,431.06 |
2,407,908,879.19 |
849,325,186.42 |
111,997,705.53 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
5,465.16 |
51,208,600.23 |
36,421,336.56 |
3,834,493.97 |
| 应付赎回款 |
59,395,202.26 |
156,897,816.54 |
71,401,967.68 |
1,361,190.73 |
| 应付管理人报酬 |
1,454,878.90 |
2,243,275.96 |
527,992.19 |
107,521.07 |
| 应付托管费 |
242,479.84 |
373,879.36 |
87,998.70 |
17,920.20 |
| 应付销售服务费 |
341,019.30 |
556,413.05 |
140,521.47 |
25,240.01 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
2,982.36 |
168.76 |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
765,330.70 |
693,372.16 |
388,596.36 |
152,187.96 |
| 负债合计 |
62,207,358.52 |
211,973,526.06 |
108,968,412.96 |
5,498,553.94 |
| 所有者权益 |
| 实收基金 |
1,080,422,497.23 |
1,372,993,886.56 |
497,300,239.82 |
121,205,987.42 |
| 未分配利润 |
334,186,575.31 |
822,941,466.57 |
243,056,533.64 |
-14,706,835.83 |
| 所有者权益合计 |
1,414,609,072.54 |
2,195,935,353.13 |
740,356,773.46 |
106,499,151.59 |
| 负债及所有者权益总计 |
1,476,816,431.06 |
2,407,908,879.19 |
849,325,186.42 |
111,997,705.53 |
微信公众号
证券之星APP
基本资料
